Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 31 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Pancreatic Cancer Detection Consortium
NCT06388967
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +18 more
- Locations
-
- Translational Genomics Research Institute Phoenix, Arizona, United States
- Honorhealth Scottsdale, Arizona, United States
- City of Hope Medical Center Monrovia, California, United States
- Hoag Center Newport Beach, California, United States
Recruiting
Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
NCT07529626
- Conditions
- Anxiety Disorders, Behavior, Behavioral Symptoms, +18 more
- Locations
-
- the Third Xiangya Hospital of Central South University Changsha, Hunan, China
- Zhongshan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
- The First Affiliated Hospital of Xi'an Jiao Tong University Xi’an, Shanxi, China
NCT03977233
- Conditions
- Cancer of Pancreas, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
NCT06496373
- Conditions
- Chemotherapy-intolerant, Digestive System Diseases, Digestive System Neoplasms, +7 more
- Locations
-
- Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
NCT06731998
- Conditions
- Agnosia, Biliary Tract Cancer, Biliary Tract Diseases, +30 more
- Locations
-
- AHN West Penn Hospital Pittsburgh, Pennsylvania, United States
NCT07081360
- Conditions
- Ampullary Cancer, Digestive System Diseases, Digestive System Neoplasms, +11 more
- Locations
-
- Liver and GIT hospital , Minia University Minya, Minya Governorate, Egypt
NCT06287749
- Conditions
- CtDNA, Liquid Biopsy, Minimal Residual Disease, +7 more
- Locations
-
- CHU de Montpellier Montpellier, Hérault, France
NCT06914349
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
- University of Thessaly Larissa, Greece
Recruiting
Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy
NCT06935448
- Conditions
- Enhanced Recovery After Surgery, Pancreatectomy, Pancreatic Cancer Resectable
- Locations
-
- University of Thessaly Larissa, Greece
NCT06722911
- Conditions
- Pancreatic Cancer Resectable
- Locations
-
- Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China
Recruiting
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
NCT06368063
- Conditions
- Pancreatic Cancer Resectable
- Locations
-
- Zheng Wang Xi'an, Shannxi, China
Not Yet Recruiting
Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer Based on Real Clinical Cases
NCT07713823
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
- Locations
-
Not specified
Not Yet Recruiting
EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer
NCT07698613
- Conditions
- Pancreatic Cancer Borderline, Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection, Pancreatic Cancer Resectable
- Locations
-
- Rhode Island and the Miriam Hospitals (Brown University Health) Providence, Rhode Island, United States
Not Yet Recruiting
A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC)
NCT07592819
- Conditions
- Pancreas Adenocarcinoma (MSI-H), Pancreatic Cancer Resectable
- Locations
-
Not specified
NCT07488884
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
Not specified
Not Yet Recruiting
Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer
NCT07469956
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, China
Not Yet Recruiting
Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer
NCT07155629
- Conditions
- Pancreatic Cancer Resectable
- Locations
-
- Helsinki University Central Hospital Helsinki, Finland
- Oulu University Hospital Oulu, Finland
Not Yet Recruiting
Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer
NCT06941987
- Conditions
- Minimal Residual Disease, Neoplasm, Residual, Neoplasms, +4 more
- Locations
-
- Zhongshan Hospital, Shanghai Shanghai, China
Not Yet Recruiting
Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.
NCT06888674
- Conditions
- Pancreatic Cancer Resectable
- Locations
-
- First Affiliated Hospital of Zhejiang University Schlool of Medicine Hangzhou, Zhejiang, China
Not Yet Recruiting
Neoadjuvant Chemotherapy for Elderly with Pancreatic Head Cancer
NCT06868693
- Conditions
- Borderline Pancreatic Inoperable Cancer, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
Not specified